Eli Lilly Corp. buy SVB Leerink LLC
Start price
07.02.26
/
50%
€920.00
Target price
07.02.27
€1,097.5
Performance (%)
10.91%
Price
14.08.26
€1,020.4
Summary
This prediction is currently active. The prediction currently has a performance of 10.91%. This prediction currently runs until 07.02.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -0.468% | -0.468% |
| iShares Core DAX® | 0.437% | 5.640% |
| iShares Nasdaq 100 | 1.057% | 0.282% |
| iShares Nikkei 225® | 1.769% | 0.406% |
| iShares S&P 500 | 0.368% | 1.920% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Leerink Partners from $1,234.00 to $1,296.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€758.50
27.04.26
27.04.26
€902.26
27.04.27
27.04.27
34.53%
14.08.26
14.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€807.50
10.11.25
10.11.25
€955.18
10.11.26
10.11.26
26.37%
14.08.26
14.08.26